Loading…
Siddha Flower Essences, LLC. was cited for significant Current Good Manufacturing Practice (CGMP) violations in its manufacturing of over-the-counter homeopathic drugs, rendering the products adulterated under federal law. The company failed to maintain proper methods, facilities, and controls for manufacturing, processing, packing, and holding finished pharmaceuticals, and failed to update its human OTC homeopathic drug listings in the FDA's Drug Registration and Listing System as required by regulation. These compliance failures resulted in the company's drug products being misbranded and improperly listed for interstate commerce, violating multiple provisions of the Federal Food, Drug, and Cosmetic Act.